In accordance with article 5 of the Spanish Law RDL1/2015, the information set out in the following sections is intended for healthcare professionals.
Access to this information and all use which may be made thereof or of these contents is exclusive responsibility of those who use them. Noventure will not be held liable for any illegal or improper use or for the manipulation of the contents and information included in these pages.
Magazine
Rhinosectan’s mode of action has been studied in experimental models with nasal mucosa cells. In these models, the presence of xyloglucan prevents the harmful action of substances known to damage the architecture of the cells. This is thanks to the protective barrier effect that comes from the mucoadhesivity of this polymer (1).